We Develop Innovative Healthcare Solutions Through Cannabis & Mushroom Based Sciences
About our studies
Psilocybin – The Active Compound found in various mushrooms. FDA granted “breakthrough therapy” status to psilocybin in 2020. Acknowledgement that Major Depressive Disorder (MDD) represents an unmet medical need and suggests that psilocybin may offer a substantial clinical improvement over existing therapies.
Cannabinoids – The active compounds found in Cannabis. Cannabinoids are commonly used to treat seizure disorder, anxiety, pneumonia, dystonia, Parkinson disease, Crohn disease, and many other conditions.
A Shortcut to your Destination
Our Science & Research
We believe that every medicine, product and brand that we develop must launch from a foundation that is backed by precise research and meticulous development programs.
Investor Portal
A general overview of our offering. Here you will find everything you will need to get involved with us in a financial capacity.
Any questions about M2Bio Sciences?
We're passionate about our industry and encourage your thoughts or ideas. We want to hear from you!